Jodie E. Giles

Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology

Lenka Hovorková, Markéta Žaliová, Nicola C. Venn et al. · Blood · 2017 · 134 citations · Full text

Life Sciences, Genetics, Pediatrics +7

Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone

Seoyeon Choi, Michelle J. Henderson, Edward Kwan et al. · Blood · 2007 · 105 citations · Full text

Medicine, Oncology, Pediatrics +12

Patterns of cognitive change over time and relationship to age following successful treatment of Cushing's disease

Julie N. Hook, Bruno Giordani, D.E. Schteingart et al. · Journal of the International Neuropsychological Society · 2006 · 80 citations

Social Sciences, Neuroscience, Psychology +17

Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia

Rosemary Sutton, Nicola C. Venn, Jonathan Tolisano et al. · British Journal of Haematology · 2009 · 62 citations · Full text

Medicine, Oncology, Pediatrics +15

Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia

Marion K. Mateos, Glenn M. Marshall, Pasquale Barbaro et al. · Haematologica · 2021 · 56 citations · Full text

Pharmacy, Oncology, Pharmacology +14